1. Xu, Qianqian, Li, Jiayi, Zhuo, Li, Yang, Yue, Li, Wenge. 2024. RACGAP1 is a pivotal gene in lung adenocarcinoma-associated membranous nephropathy: Based on comprehensive bioinformatics analysis and machine learning. In International immunopharmacology, 139, 112783. doi:10.1016/j.intimp.2024.112783. https://pubmed.ncbi.nlm.nih.gov/39068752/
2. Hernández, Gonzalo, Romero-Cortadellas, Lídia, Ferrer-Cortès, Xènia, Segovia, Jose-Carlos, Sánchez, Mayka. 2023. Mutations in the RACGAP1 gene cause autosomal recessive congenital dyserythropoietic anemia type III. In Haematologica, 108, 581-587. doi:10.3324/haematol.2022.281277. https://pubmed.ncbi.nlm.nih.gov/36200420/
3. Li, Wenjie, Wang, Rong, Wang, Wei. 2023. Exploring the causality and pathogenesis of systemic lupus erythematosus in breast cancer based on Mendelian randomization and transcriptome data analyses. In Frontiers in immunology, 13, 1029884. doi:10.3389/fimmu.2022.1029884. https://pubmed.ncbi.nlm.nih.gov/36726984/
4. Eid, Refaat A, Soltan, Mohamed A, Eldeen, Muhammad Alaa, Abdel-Daim, Mohamed M, Kim, Bonglee. 2022. Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. In International journal of molecular sciences, 23, . doi:10.3390/ijms232214102. https://pubmed.ncbi.nlm.nih.gov/36430577/
5. Wang, Jiajia, Liu, Hui, Yu, Zeyuan, Hu, Jing, Han, Bo. 2024. Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancer. In Cell communication and signaling : CCS, 22, 339. doi:10.1186/s12964-024-01703-w. https://pubmed.ncbi.nlm.nih.gov/38898473/
6. Edwards, Jonathan J, Rouillard, Andrew D, Fernandez, Nicolas F, Ma'ayan, Avi, Gelb, Bruce D. 2020. Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects. In JACC. Basic to translational science, 5, 376-386. doi:10.1016/j.jacbts.2020.01.012. https://pubmed.ncbi.nlm.nih.gov/32368696/
7. Song, Zhengshuai, Cao, Qi, Guo, Bin, Ruan, Hailong, Guo, Yonglian. 2023. Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression. In Aging and disease, 14, 1757-1774. doi:10.14336/AD.2023.0202. https://pubmed.ncbi.nlm.nih.gov/37196108/
8. Wu, Xianjian, Xu, Zuoming, Li, Wenchuan, Lu, Yuan, Pu, Jian. 2023. HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way. In Molecular medicine reports, 28, . doi:10.3892/mmr.2023.13105. https://pubmed.ncbi.nlm.nih.gov/37772389/
9. Zhang, Tianli, Wang, Chunyan, Wang, Kun, Feng, Liping, Yang, Xingsheng. 2022. RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK. In Cell death & disease, 13, 604. doi:10.1038/s41419-022-05036-9. https://pubmed.ncbi.nlm.nih.gov/35831303/
10. Ren, Kehan, Zhou, Danmei, Wang, Meili, Zhou, Ping, Liu, Xiuping. 2021. RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis. In Experimental cell research, 400, 112493. doi:10.1016/j.yexcr.2021.112493. https://pubmed.ncbi.nlm.nih.gov/33485843/